Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339 Read more here
Read More
Yaupon Therapeutics, Inc. Secures $14.4 Million in Series D Financing Read more here
Read More
Yaupon Therapeutics, Inc. Submits New Drug Application for Proprietary Gel Formulation of Mechlorethamine Hydrochloride Read more here
Read More
Yaupon Therapeutics, Inc. Appoints New Management Team Read more here
Read More
First-In-Class Novel Anti-Cancer Agent In Development By Niiki Pharma Shows Promising Phase I Results Read more here
Read More
Infrascanner™ Software Designer Wins the Design of Medical Devices Top Award Read more here
Read More
Yaupon Therapeutics Names Steve Tullman Chairman and Chief Executive Officer Read more here
Read More
Jeffrey Cummings, Rachelle Doody, Martin Farlow and Mary Sano to Form QR Pharma's Medical Advisory Board Read more here
Read More
TREVENTIS Corporation Founder Wins Prestigious Discovery Award Read more here
Read More
TREVENTIS Corporation Moves to New Facilities in NRC Incubation Space Read more here
Read More
Infrascanner Handheld Brain Scanner Experiences Significant Sales Growth in Romania, Bucharest Read more here
Read More
NIH Proposes New Center to Accelerate Drug Development Read more here
Read More
Yaupon Announces Positive from Pivotal Study Read more here
Read More
QR Pharma Receives FDA Clearance to Conduct Clinical Trials with its Second Novel Alzheimer Compound, Bisnorcymserine Read more here
Read More
Jenrin Adds Twist in Quest for Drug to Battle Obesity Read more here
Read More
Phoenix S&T Featured as a Member of the Keystone Innovation Zone Dedicated to Improving Human Health
Phoenix S&T Featured as a Member of the Keystone Innovation Zone Dedicated to Improving Human Health Read more here
Read More
BioAdvance Wins Local Venture Impact Award Read more here
Read More
BioAdvance Wins Venture Impact Award (Philadelphia Business Journal) Read more here
Read More